It has been reported that Akt2 abnormally activated by PI3K small molecule inhibitors (PI3Ki) in glioblastoma cells can translocate to mitochondria and subsequently phosphorylate CypD at S31 (61). This evidence concerns the gene AKT2 and glioblastoma.